Hu, Yu

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 7,166

Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome

Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., et al. (2020) · Science Immunology

CAR-T cell therapy researchInflammasome and immune disorders

Cited by 566

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma

Mei, H., Li, C., Jiang, H., Zhao, X., Huang, Z., Jin, D., Guo, T., Kou, H., Liu, L., Tang, L., et al. (2021) · Journal of Hematology & Oncology

CAR-T cell therapy researchMultiple Myeloma Research and Treatments

Cited by 222

Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow–derived mesenchymal stem cells and slow age-related degeneration

Lei, Q., Gao, F., Liu, T., Ren, W., Chen, L., Cao, Y., Chen, W., Guo, S., Zhang, Q., Chen, W., et al. (2021) · Science Translational Medicine

Extracellular vesicles in diseaseMesenchymal stem cell research

Cited by 170

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Zhang, B., Hu, Y., & Pang, Z. (2017) · Frontiers in Pharmacology

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 152

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Jiang, Q., Li, Z., Qin, Y., Li, W., Xu, N., Liu, B., Zhang, Y., Meng, L., Zhu, H., Du, X., et al. (2022) · Journal of Hematology & Oncology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 102

Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis

Liu, Q., Wang, X., Hu, Y., Zhao, J.-N., Huang, C.-H., Li, T., Zhang, B.-G., He, Y., Wu, Y.-Q., Zhang, Z.-J., et al. (2023) · Redox Biology

Alzheimer's disease research and treatmentsMitochondrial Function and Pathology

Cited by 58

Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice

Zhang, B., Jin, K., Jiang, T., Wang, L., Shen, S., Luo, Z., Tuo, Y., Liu, X., Hu, Y., & Pang, Z. (2017) · Scientific Reports

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 49

Optimization of the tumor microenvironment and nanomedicine properties simultaneously to improve tumor therapy

Zhang, B., Shi, W., Jiang, T., Wang, L., Mei, H., Lu, H., Hu, Y., & Pang, Z. (2016) · Oncotarget

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranostics

Cited by 41

Captopril improves tumor nanomedicine delivery by increasing tumor blood perfusion and enlarging endothelial gaps in tumor blood vessels

Zhang, B., Jiang, T., Tuo, Y., Jin, K., Luo, Z., Shi, W., Mei, H., Hu, Y., Pang, Z., & Jiang, X. (2017) · Cancer Letters

Nanoparticle-Based Drug DeliveryAngiogenesis and VEGF in Cancer

Cited by 41